Recent initiatives around the world are making a difference for endometriosis patients.

• Luxembourg, August: Parliament is set to debate flexible work hours for endometriosis patients, following a citizen petition.
• Sweden, May: A seminar on endometriosis for members of the Swedish and EU parliaments features speakers from the Swedish and German advocacy groups and from the EU-funded FEMaLe project.
• Belgium, April: The national government appoints a working group to improve endometriosis care.
• Australia, February: The Queensland government commits AUS$18M to enhance support and treatment access for women with endometriosis.

These steps towards raising awareness, advocating for better care, and improving the lives of those affected by endometriosis are not only crucial for the countries involved but also serve as inspiring examples for others to follow.

Gesynta Pharma is dedicated to the development of better treatments for endometriosis patients, with promising preclinical data for vipoglanstat and a phase II study coming.